{"id":3464,"date":"2025-03-25T06:42:16","date_gmt":"2025-03-25T11:42:16","guid":{"rendered":"https:\/\/www.molllawgroup.com\/blog\/?p=3464"},"modified":"2025-03-11T09:37:46","modified_gmt":"2025-03-11T14:37:46","slug":"ozempic-and-wegovy-linked-to-vision-loss","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/","title":{"rendered":"Ozempic and Wegovy Linked to Vision Loss"},"content":{"rendered":"

\"medical-5835701_640-e1741657233713\"Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to manage type 2 diabetes and obesity and have the potential to help other medical problems like depression, addiction, and Alzheimer\u2019s. Unfortunately, it also appears that one of the drugs\u2019 potential side effects is a rare kind of vision loss, non-arteritic anterior ischemic optic neuropathy (NAION<\/a>). Around 12% of people around the country has taken semaglutide drugs and around 6% of Americans are currently taking them. No direct causal link has been established, but as popularity of these drugs grow, it\u2019s important to be aware of this possible risk. If you suffered NAION while on Ozempic, Wegovy or another GLP-1 drug, you should call the seasoned Chicago-based dangerous pharmaceuticals lawyers of Moll Law Group.<\/p>\n

Call Moll Law Group About Your Semaglutide Claim<\/strong><\/p>\n

Only a small group of patients taking semaglutide have experienced vision issues. A JAMA study, one of several studies, looked at 9 patients that had vision trouble while taking semaglutide.<\/p>\n

NAION is a non-inflammatory disease in which the blood supply to the optic nerve is harmed and the patient suffers a sudden partial vision loss that\u2019s permanent. The study was initiated because a patient experienced a painless vision loss while on the drug but had the issue resolve favorably when semaglutide was stopped; when he went back on, he had the same problem with the other eye. The researcher looked into whether other neuro-ophthalmologists had seen this in their patients and found nine cases that are featured in his study. Seven out of nine of the patients, all of them in their 50s and 60s, had typical presentations of NAION, which usually affects only one eye at once, but some had unusual symptoms. Researchers are trying to figure out whether being on semaglutide actually causes NAION and other vision loss.<\/p>\n

Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to manage type 2 diabetes and obesity and have the potential to help other medical problems like depression, addiction, and Alzheimer\u2019s. Unfortunately, it also appears that one of the drugs\u2019 potential […]<\/p>\n","protected":false},"author":2,"featured_media":3466,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,34,3],"tags":[],"class_list":["post-3464","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceuticals","category-prescription-drug-injuries","category-product-liability"],"yoast_head":"\nOzempic and Wegovy Linked to Vision Loss — Illinois Injury and Mass Tort Lawyer Blog — March 25, 2025<\/title>\n<meta name=\"description\" content=\"Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to — March 25, 2025\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Ozempic and Wegovy Linked to Vision Loss — Illinois Injury and Mass Tort Lawyer Blog — March 25, 2025\" \/>\n<meta name=\"twitter:description\" content=\"Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to — March 25, 2025\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2025\/03\/medical-5835701_640-e1741657233713.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ozempic and Wegovy Linked to Vision Loss — Illinois Injury and Mass Tort Lawyer Blog — March 25, 2025","description":"Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to — March 25, 2025","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/","twitter_card":"summary_large_image","twitter_title":"Ozempic and Wegovy Linked to Vision Loss — Illinois Injury and Mass Tort Lawyer Blog — March 25, 2025","twitter_description":"Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to — March 25, 2025","twitter_image":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2025\/03\/medical-5835701_640-e1741657233713.jpg","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Ozempic and Wegovy Linked to Vision Loss","datePublished":"2025-03-25T11:42:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/"},"wordCount":532,"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2025\/03\/medical-5835701_640-e1741657233713.jpg","articleSection":["Pharmaceuticals","Prescription Drug Injuries","Product Liability"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/","url":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/","name":"Ozempic and Wegovy Linked to Vision Loss — Illinois Injury and Mass Tort Lawyer Blog — March 25, 2025","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/#primaryimage"},"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2025\/03\/medical-5835701_640-e1741657233713.jpg","datePublished":"2025-03-25T11:42:16+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Semaglutide in the form of drugs like Ozempic, Mounjaro, Wegovy, Rybelsus and Zepbound may increase the risks of vision loss. These drugs are taken to — March 25, 2025","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/#primaryimage","url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2025\/03\/medical-5835701_640-e1741657233713.jpg","contentUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2025\/03\/medical-5835701_640-e1741657233713.jpg","width":600,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/ozempic-and-wegovy-linked-to-vision-loss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Ozempic and Wegovy Linked to Vision Loss"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2025\/03\/medical-5835701_640-e1741657233713.jpg","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=3464"}],"version-history":[{"count":2,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3464\/revisions"}],"predecessor-version":[{"id":3467,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3464\/revisions\/3467"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media\/3466"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=3464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=3464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=3464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}